Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 PK/PD Interaction with Warfarin and Esmolol
NCT03347968Phase 1Completed
- Sponsor
- MedImmune
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cotadutide in type 2 diabetes mellitus (T2DM) and Nonalcoholic steatohepatitis (NASH), sponsored by MedImmune. Primary endpoints: Maximum international normalized ratio and Change in heart rate from resting after a 9-minute excercise treadmill test. Started Nov 2017; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03347968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347968.